CSL BEHRING LLC for CSL BEHRING LLC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Immigration IMM
Customs and Border protection policy change on allowing B1/B2 visa holders to cross the US border to donate plasma.
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| MARY LACEY REUTHER New | — |
Health Issues HCR
HR 5376--Build Back Better Act--Medicare Part D restructure, direct negotiation of Medicare pricing, restriction on use of orphan drug tax credit HR 3808--Medicare IVIG Access Enhancement Act--Coverage for Intravenous immune globulin in the home under Medicare Part B when used for chronic inflammatory demyelinating polyneuropathy. S. 1281, HR 3468--Plasma Donation Awareness Act--Adding "and plasma" to the Blood Donation Awareness Campaign created by the CARES Act. Highlighting the importance and need of plasma collection as the raw material to manufacture therapies in treating rare diseases.
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| MARY LACEY REUTHER New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.